No abstract

The rate of consanguineous mating in north Jordan was 63-7% with an average inbreeding coefficient of 00283. First cousin marriages were the most predominant type (58-5%); villagers showed higher levels than city dwellers. The level of female education did not influence consanguinity rate.

Most studies examining the developmental aspects of renin secretion in fetal lambs have focused on measurements of active renin. Data from these studies demonstrated age-dependent differences in renin release in vivo and in vitro. However, little information is available concerning gestational changes in total (active and inactive) renin. Therefore, we have measured the renin concentration in plasma, amniotic fluid and various tissues before and after trypsin treatment (for total renin) using 7 fetuses at 0.61–0.79 gestation (immature) and 7 fetuses at 0.88–0.97 gestation (mature). We found that active and total renin levels in plasma and kidney tissues were significantly lower in immature than in mature fetuses, while inactive renin levels were not different. We also found that the amniotic fluid, the adrenal gland, the placenta and membranes all contained low levels of active and total renin that were not different between groups. These results suggest that, over the last third of gestation, maturation influences the regulation of active renin in the kidney and plasma. The data also indicate that the renin concentration in the amniotic fluid, the adrenals, the placenta and membranes is regulated differently than that in the plasma and the kidney.

The acetylator phenotype was determined in 31 insulin-dependent (IDDM) and 110 noninsulin-dependent (NIDDM) Jordanian diabetics, and was compared to that of 160 healthy volunteers of the same ethnic group. Dapsone was used as the test drug. The rapid acetylator phenotype was slightly less frequent in IDDM and slightly more frequent in NIDDM. Neither of the differences was significant. When acetylator status in the two types of diabetes mellitus was compared, there was a significant difference among the two groups. Patients with IDDM had a higher percentage of the slow acetylator phenotype when compared to NIDDM patients. The association between acetylator status and IDDM in Jordanians, which agrees with that reported for the Saudi Arabian population, is the reverse of what is found in European populations. The results demonstrate ethnic differences in acetylator status among IDDM patients.

The pharmacokinetic parameters (AUC, Cmax, Tmax, and t1/2) of nifedipine following single oral administration of a 10 mg capsule of test product were compared to those of the same amount of a reference product. The two products in capsule form were administered according to a randomized two-way crossover design in 22 healthy male volunteers. Nifedipine plasma concentrations were determined using a rapid, sensitive and precise high performance liquid chromatography (HPLC) method with ultraviolet (UV) detection at 235 nm. The parametric 90% confidence intervals of the mean value of the ratio [Myogard (test product) /Adalat (reference product)] for pharmacokinetic parameters were 0.90-1.08, 0.80-1.07, and 0.93-1.12 for AUC0-->infinity, Cmax and t1/2, respectively. In each case, values were within the acceptable bioequivalence range of 0.8-1.25. Distribution free point estimate for the difference in expected medians of Tmax of the two products (Myogard-Adalat) was 0.00 h with a 90% confidence interval of 0.00-0.13 which is greater than the accepted bioequivalence of +/- 0.12. The kinetic parameters were comparable to those reported for nifedipine, and no statistically significant differences were found in any of them when comparing the two products by analysis of variance (ANOVA) on log-transformed data. Thus, the two products could be considered bioequivalent regarding absorption rate (Cmax and Tmax), extent of absorption (Cmax and AUC) and elimination (t1/2).